Invesco Funds - Invesco China Health Care Equity Fund Z EUR Hedged AccRegistrati per vedere i rating |
Storico dei rendimenti | 31/10/2024 |
Crescita di 1000 (EUR) | Grafico Interattivo |
Sintesi | ||
NAV 22/11/2024 | EUR 4,370 | |
Var.Ultima Quotazione | -3,96% | |
Categoria Morningstar™ | Azionari Altro | |
Categoria Assogestioni | Azionari salute | |
Isin | LU2305833589 | |
Fund Size (Mil) 22/11/2024 | CNH 389,47 | |
Share Class Size (Mil) 22/11/2024 | EUR 1,48 | |
Entrata (max) | - | |
Spese correnti 15/11/2024 | 1,15% |
Obiettivo d'Investimento Dichiarato: Invesco Funds - Invesco China Health Care Equity Fund Z EUR Hedged Acc |
The Fund aims to achieve long term capital growth. The Fund seeks to achieve its objective by investing primarily in a concentrated portfolio of Chinese healthcare companies. Such companies will be listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect (which may include companies listed on the ChiNext Board or the Science and Technology Innovation (STAR) board) as well as those listed or traded elsewhere, included via QFI. |
Rendimenti % (EUR) | |||||||||||||
|
Gestione | ||
Nome del Gestore Inizio Gestione | ||
Chris Liu 15/12/2020 | ||
Kehong Jiang 31/01/2024 | ||
Data di Partenza 03/03/2021 |
Pubblicità |
Indice | |
Benchmark Dichiarato | Indice di Categoria Morningstar |
MSCI CHINA A ONSHORE/HEALTH CARE NR LCL | - |
Target Market | ||||||||||||||||||||
|
Composizione del Fondo Invesco Funds - Invesco China Health Care Equity Fund Z EUR Hedged Acc | 31/10/2024 |
|
|
Primi 5 Titoli | Settore | % |
Mehow Innovative Ltd Class A | Salute | 6,78 |
Jiangsu Hengrui Pharmaceuticals ... | Salute | 5,65 |
Humanwell Healthcare (Group) Co ... | Salute | 5,59 |
BeiGene Ltd Class A | Salute | 4,85 |
Zhejiang Huahai Pharmaceutical C... | Salute | 4,40 |
Incremento Decremento Nuova Posizione | ||
Invesco Funds - Invesco China Health Care Equity Fund Z EUR Hedged Acc |